Experts recommend Covaxin for phase 2/3 trials on those aged 2-18 year


Team Udayavani, May 12, 2021, 9:57 AM IST

New Delhi: Bharat Biotech’s COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years, official sources said.

The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur.

The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) on Tuesday deliberated upon Hyderabad-based Bharat Biotech’s application seeking permission to conduct phase II/III clinical trials to evaluate the safety, reactogenicity and immunogenicity of Covaxin jabs in children aged 2 to 18 years.

“After detailed deliberation, the committee recommended for conduct of proposed phase II/III clinical trial of whole virion inactivated coronavirus vaccine in the 2 to 18 years age group subject to the condition that the firm should submit the interim safety data of phase II clinical trial along with DSMB recommendations to the CDSCO before proceeding to phase III part of the study,” a source said.

Earlier the proposal was deliberated in the SEC meeting dated February 24 and the firm was asked to submit a revised clinical trial protocol.

Covaxin, indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is being used in adults in India’s ongoing COVID-19 vaccination drive.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

NTT DATA Sponsors 12-day coaching camp for the top 56 visually impaired cricketers of CABI

ED conducts raids against Vivo, related companies in money laundering probe

Over 20 houses inundated in Ullal; Kalladka-Kanhangad highway blocked after mudslide in Vittal

Arrest of senior bureaucrats; “Will cleanse system,” says, CM Bommai

Active COVID-19 cases in country climb to 1,14,475

Researchers develop new N95 face mask that can kill Covid virus

Mangaluru rains: Three injured after compound wall collapsed


Related Articles More

PM Modi to inaugurate golden jubilee celebrations of Agradoot group of newspapers

ED conducts raids against Vivo, related companies in money laundering probe

Chhattisgarh cops reach UP to arrest TV anchor over ‘out of context’ Rahul Gandhi video

Droupadi Murmu visits Patna to seek support for presidential election

Active COVID-19 cases in country climb to 1,14,475

MUST WATCH

sidhu moose wala shooters seen waving guns celebrating in car

NEWS BULLETIN 04-07-2022

Tourist gathering, Road Block at Charmadi Ghat

Heavy Rain at Kalasa : Horanadu Kalasa Road Block

NEWS BULLETIN 03-07-2022


Latest Additions

NTT DATA Sponsors 12-day coaching camp for the top 56 visually impaired cricketers of CABI

PM Modi to inaugurate golden jubilee celebrations of Agradoot group of newspapers

ED conducts raids against Vivo, related companies in money laundering probe

Over 20 houses inundated in Ullal; Kalladka-Kanhangad highway blocked after mudslide in Vittal

Chhattisgarh cops reach UP to arrest TV anchor over ‘out of context’ Rahul Gandhi video

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.